MedPath

The optimal target for acute glycemic control in critically ill patients: update systematic review

Not Applicable
Conditions
Critically ill patients.
Registration Number
JPRN-UMIN000049483
Lead Sponsor
Guideline committee of The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2024
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up continuing
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

Not provided

Exclusion Criteria

Conference abstract

Study & Design

Study Type
Others,meta-analysis etc
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
ong-term mortality (more than 60 days), 28 or 30 days mortality, and in-hospital mortality.
Secondary Outcome Measures
NameTimeMethod
Incidences of hypoglycemia (defined as blood glucose levels of <40 mg/dL or hypoglycemia-associated symptoms), sepsis and bloodstream infection.
© Copyright 2025. All Rights Reserved by MedPath